The role of growth hormone device optimization in patient-reported outcomes: real-world evidence from South Korea-Reference-Cited by-同舟云学术

The role of growth hormone device optimization in patient-reported outcomes: real-world evidence from South Korea

Published:2021-01-02 Issue:1 Volume:18 Page:91-106
ISSN:1743-4440
Container-title:Expert Review of Medical Devices
language:en
Short-container-title:Expert Review of Medical Devices

Author:

Lee Ji-Eun¹^ORCID,Lee Kee-Hyoung²,Park Mi Jung³^ORCID,Yang Seung⁴^ORCID,Kim Eun Young⁵,Rhie Young-Jun⁶,Jung Min-Ho⁷,Yang Aram⁸,Kim Shin-Hye³^ORCID,Chung Lindsey Yoojin⁹,Ko Su Young⁵,Lee Young Ju¹⁰,Nedjatian Navid¹¹^ORCID,Chung Woo Yeong¹²^ORCID

Affiliation:

1. Inha University Hospital, Incheon, Korea

2. Korea University Anam Hospital, Seoul, Korea

3. Inje University Sanggye Paik Hospital, Seoul, Korea

4. Hanyang University Guri Hospital, Guri, Korea

5. Chosun University Hospital, Gwangju, Korea

6. Korea University Ansan Hospital, Seoul, Korea

7. The Catholic University of Korea Yeouido St Mary’s Hospital, Seoul, Korea

8. Kangbuk Samsung Hospital, Seoul, Korea

9. Myongji Hospital, Goyang, Korea

10. Medical Affairs, Novo Nordisk Pharma Korea Ltd, Seoul, Korea

11. Global Medical Affairs, Novo Nordisk Health Care AG, Zurich, Switzerland